ストックスクリーナーアプリを入手
1.41
2.09%
-0.0199
前日終値:
$1.4299
開ける：
$1.43
24時間の取引高:
63,808
Relative Volume:
0.66
時価総額：
$10.90M
収益：
-
当期純損益:
$-17.57M
株価収益率:
1.9101
EPS:
0.7382
ネットキャッシュフロー:
$-16.44M
1週間 パフォーマンス:
+32.08%
1か月 パフォーマンス:
+22.81%
6か月 パフォーマンス:
-15.66%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.355
$1.4972
1週間の範囲:
$1.06
$1.4972
52週間の値動き範囲:
$0.95
$3.92
Check Cap Ltd Stock (MBAI) Company Profile
Compare MBAI vs TMO, DHR, IDXX, NTRA, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MBAI
Check Cap Ltd
|
1.41 | 8.27M | 0 | -17.57M | -16.44M | 0.7382 |
TMO
Thermo Fisher Scientific Inc
|
587.31 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.68 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
588.02 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
318.30 | 36.95B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
145.14 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
Check Cap Ltd Stock (MBAI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-12-05 | 開始されました | Dawson James | Buy |
| 2018-01-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-09-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-01-19 | 開始されました | Rodman & Renshaw | Buy |
| 2016-08-01 | 繰り返されました | Maxim Group | Buy |
| 2016-05-20 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-03-16 | 繰り返されました | Chardan Capital Markets | Buy |
| 2016-01-19 | 繰り返されました | Maxim Group | Buy |
| 2015-10-09 | 開始されました | Maxim Group | Buy |
| 2015-07-22 | 繰り返されました | Chardan Capital Markets | Buy |
| 2015-05-01 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Check Cap Ltd (MBAI) 最新ニュース
Check Cap Ord Shs (MBAI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Check Cap Ord Shs (MBAI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Check Cap Ord Shs (MBAI) Balance Sheet - TradingKey
MBAI|Check Cap Ord Shs|Price:1.080|Chg%:-0.020 - TradingKey
MBAI|Check Cap Ord Shs|Price:1.090|Chg%:+0.020 - TradingKey
Check Cap Ord Shs (MBAI) Institutional Confidence - TradingKey
Check Cap Ord Shs (MBAI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Check Cap Ord Shs (MBAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MBAI|Check Cap Ord Shs|Price:1.048|Chg%:-0.022 - TradingKey
Check Cap Ord Shs (MBAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Check Cap Ord Shs (MBAI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Changes in working capital of Check-Cap Ltd. – NASDAQ:MBAI - TradingView
Check-Cap Ltd. Revenue Breakdown – FWB:7CC - TradingView
Check-Cap Ltd. (NASDAQ: MBAI) plans MBody AI merger and new share offering - Stock Titan
Check-Cap Ltd Announces Firm Commitment Public Offering Of Ordinary SharesSEC Filing - TradingView
SJM: J.M. Smucker Co. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Price to book forward of Check-Cap Ltd. – SWB:7CC - TradingView
Check-Cap (CHEK) Q4 2025 earnings summary - Quartr
MBAI StockAI Robotics Company To Watch Arisa Dimagrita (8z3YrojNYd) - Mshale
Check-Cap: MBody AI Advances Its Robot Fleet Operating System with Multi-Robot Control - StreetInsider
Check-Cap: MBody AI Brings AI Robotics to Buyers Edge Platform Operators, Manufacturers and Distributors - AI Magazine
Mbody Ai Corp Enters Referral and Channel Partner Agreement with Buyers Edge Platform Opco Llc - marketscreener.com
Humanoid Global Announces MBody AI’s Advancements in Commercial Expansion and Proposed Business Combination with Check-Cap - The Manila Times
Humanoid Global Announces MBody AI’s Advancements in - GlobeNewswire
Enterprise value to EBITDA forward of Check-Cap Ltd. – FWB:7CC - TradingView
Humanoid Global Announces MBody AI's Advancements in Commercial Expansion and Proposed Business Combination With Check-Cap - Moomoo
Price to earnings forward of Check-Cap Ltd. – FWB:7CC - TradingView
Enterprise value to revenue forward of Check-Cap Ltd. – FWB:7CC - TradingView
Price to sales forward of Check-Cap Ltd. – MUN:7CC - TradingView
Enterprise value to EBIT forward of Check-Cap Ltd. – MUN:7CC - TradingView
Check-Cap Ltd. (MBAI) Q3 2023 Earnings: Wider-than-Expected Loss Amidst R&D ProgressNew Analyst Coverage - DonanımHaber
Check-Cap Ltd explores colorectal cancer screening technology. Investor interest focuses on the caps - Ad-hoc-news.de
MBAI Q3 2023 Earnings: Wider-than-Expected Loss Reflects Development-Stage CostsAnalyst Earnings Estimate - dars.gov.et
MBAICheck-Cap Ltd Latest SEC Filings - Finviz
MBody AI expands service robotics operations to eleven states and Canada - The Robot Report
Check-Cap: MBody AI Expands Robotics Footprint Across U.S. and Canada - markets.businessinsider.com
MBody AI expands to 11 U.S. states, enters Canada market By Investing.com - Investing.com Nigeria
Check-Cap Highlights MBody AI’s North American Robotics Expansion as Merger Advances - TipRanks
MBody AI expands to 11 U.S. states, enters Canada market - Investing.com
MBody AI expansion and merger progress with Check-Cap (NASDAQ: MBAI) - Stock Titan
Check-Cap Ltd. Actuals & Estimates (TRADEGATE:7CC) - TradingView
Check-Cap Ltd. Actuals & Estimates (SWB:7CC) - TradingView
Check Cap Ltd (CHEK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Check-Cap (MBAI) Stock Forecast and Price Target 2026 - MarketBeat
Check-Cap Ltd. Actuals & Estimates (NASDAQ:MBAI) - TradingView
Check-Cap Ltd. Actuals & Estimates (LS:A14QUF) - TradingView
MBody AI–Check-Cap (NASDAQ: MBAI) reverse recap shows 2025 pro forma profit - Stock Titan
MBAI Q3 2023 Earnings: EPS Falls Short of Estimates as Pre-Revenue Stage ContinuesEarnings Yield Analysis - dars.gov.et
Check-Cap Ltd. (MBAI) Q3 2023 Earnings: Wider-Than-Expected Loss Amid Pre-Revenue Clinical Progress - dars.gov.et
MBAI Q3 2023 Earnings: EPS Misses Estimates Amid Ongoing Development EffortsCEO Earnings Statement - dars.gov.et
Check Cap Ltd (MBAI) 財務データ
収益
当期純利益
現金流量
EPS
0.12%
大文字化:
|
ボリューム (24 時間):